On August 17, we held a virtual roundtable discussion of step therapy in which we convened patients, advocates, caregivers, providers, industry, payers, and other stakeholders for a discussion on the impact of step therapy. The discussion provided tools for those impacted by step therapy to help navigate their individual circumstances and share resources on how all stakeholders can advocate for meaningful reform. Our panelists addressed how, in addition to putting patient lives and health outcomes at risk, step therapy leads to increased costs across the health system, including for the health

CSC’s Cancer Policy Institute hosted a webinar focused on the roles of Pharmacy Benefit Managers and Laboratory Benefit Managers with guest speakers Adam Borden from the American Clinical Laboratory Association, Greg Gierer from Better Medicare Alliance, and Rachel Klein from The Aids Institute.